14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.250 $0.498 Friday, 3rd May 2024 KZIA stock ended at $0.272. This is 3.72% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 14.81% from a day low at $0.270 to a day high of $0.310.
90 days $0.187 $0.498
52 weeks $0.187 $1.39

Historical Kazia Therapeutics Limited prices

Date Open High Low Close Volume
May 03, 2024 $0.299 $0.310 $0.270 $0.272 389 022
May 02, 2024 $0.300 $0.310 $0.270 $0.283 412 654
May 01, 2024 $0.340 $0.340 $0.286 $0.299 676 948
Apr 30, 2024 $0.351 $0.367 $0.319 $0.335 105 435
Apr 29, 2024 $0.375 $0.375 $0.355 $0.355 41 945
Apr 26, 2024 $0.373 $0.389 $0.357 $0.370 55 078
Apr 25, 2024 $0.388 $0.402 $0.340 $0.370 165 466
Apr 24, 2024 $0.382 $0.400 $0.373 $0.389 103 928
Apr 23, 2024 $0.371 $0.410 $0.365 $0.395 135 525
Apr 22, 2024 $0.403 $0.407 $0.370 $0.377 118 889
Apr 19, 2024 $0.341 $0.407 $0.335 $0.376 295 984
Apr 18, 2024 $0.345 $0.370 $0.330 $0.346 266 441
Apr 17, 2024 $0.299 $0.389 $0.287 $0.344 288 311
Apr 16, 2024 $0.296 $0.310 $0.250 $0.291 309 655
Apr 15, 2024 $0.358 $0.370 $0.296 $0.307 455 281
Apr 12, 2024 $0.340 $0.378 $0.337 $0.356 331 856
Apr 11, 2024 $0.416 $0.430 $0.357 $0.360 487 126
Apr 10, 2024 $0.478 $0.480 $0.367 $0.427 1 009 396
Apr 09, 2024 $0.400 $0.498 $0.400 $0.459 1 092 977
Apr 08, 2024 $0.370 $0.420 $0.360 $0.405 753 267
Apr 05, 2024 $0.350 $0.395 $0.345 $0.364 971 642
Apr 04, 2024 $0.340 $0.340 $0.325 $0.333 185 449
Apr 03, 2024 $0.329 $0.340 $0.316 $0.337 119 590
Apr 02, 2024 $0.330 $0.340 $0.305 $0.329 214 417
Apr 01, 2024 $0.320 $0.336 $0.295 $0.325 250 961
Click to get the best stock tips daily for free!

About Kazia Therapeutics Limited

Kazia Therapeutics Limited Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Thera... KZIA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT